Ivf Hartmann Holding Stock

CHF140.50

1.44% yesterday

SIX Swiss Exchange, Jul 09, 05:30 pm CET

ISIN

CH0187624256

Symbol

VBSN

Sector

Health

Industry

Medical specialties

Overview Dividends Analysts Charts Strategies

Ivf Hartmann Holding Stock price

CHF140.50

-3.56 2.47% 5Y

SIX Swiss Exchange, Closing price Wed, Jul 09 2025

+2.00 1.44%

ISIN

CH0187624256

Symbol

VBSN

Sector

Health

Industry

Medical specialties

Key metrics

Basic

Market capitalization

CHF325.3m

Enterprise Value

CHF217.2m

Net debt

positive

Cash

CHF108.9m

Shares outstanding

2.4m

Valuation (TTM | estimate)

P/E

16.4 | -

P/S

2.0 | -

EV/Sales

1.4 | -

EV/FCF

12.2

P/B

2.1

Dividends

DPS

CHF6.20

Yield 1Y | 5Y

2.3% | 2.2%

Growth 1Y | 5Y

1.9% | 6.3%

Payout 1Y | 3Y

95.1% | 62.8%

Increased

3 Years

Financials (TTM | estimate)

Revenue

CHF158.8m | -

EBITDA

CHF28.2m | -

EBIT

CHF22.5m | -

Net Income

CHF20.3m | -

Free Cash Flow

CHF17.8m

Growth (TTM | estimate)

Revenue

7.3% | -

EBITDA

28.6% | -

EBIT

36.8% | -

Net Income

34.0% | -

Free Cash Flow

-43.3%

Financial Health

Equity Ratio

80.4%

Return on Equity

13.4%

ROCE

14.4%

ROIC

32.0%

Debt/Equity

0.0

EPS

CHF8.5

FCF per Share

CHF7.4

Short interest

Employees

270

Rev per Employee

CHF590.0k

As a Free StocksGuide user, you can view scores for all 7,004 stocks worldwide.

Get Started for Free Today

Ivf Hartmann Holding Stock Analysis

Unlock Scores for Free

??

Financial data from Ivf Hartmann Holding

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Dec '24		+/- %
Revenue	159 159	7% 7% 100%
- Direct Costs	69 69	1% 1% 44%
Gross Profit	90 90	12% 12% 56%
- Selling and Administrative Expenses	31 31	3% 3% 19%
- Research and Development Expense	- -	- -
EBITDA	28 28	29% 29% 18%
- Depreciation and Amortization	5.75 5.75	4% 4% 4%
EBIT (Operating Income) EBIT	22 22	37% 37% 14%
Net Profit	20 20	34% 34% 13%

In millions CHF.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

Company Profile

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. It operates through the following segments: Wound Management, Incontinence Management, Risk Prevention, Disinfection, Personal Healthcare, and Facility Products. The Wound Management segment provides traditional wound treatment; negative pressure wound therapy; as well as compression and support therapy. The Incontinence Management segment offers securing systems; medicinal skin care; including patient and personal hygiene. The Risk Prevention segment provides disposable surgical instruments, surgical clothing, as well as surgical and examination gloves. The Disinfection segment sells hand disinfection, hand protection, and skin disinfection. The Personal Healthcare segment markets plaster and wound dressings; thermometers; and sphygmomanometers. The Facility Products segment supplies hygienic paper, microfiber wipes, and foils products. The company was founded on April 13, 1883 and is headquartered in Neuhausen, Switzerland.

Head office	Switzerland
CEO	Claus Martini
Employees	270
Founded	1883
Website	www.ivf.hartmann.info

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now